Skip to main

AST Letter to MolDX: Molecular Testing for Solid Organ Allograft Rejection

Share

The AST recently submitted a letter to MolDX regarding the recent decision to limit reimbursement coverage for molecular diagnostics for transplantation such as donor derived cell free (cf)DNA and gene expression profiling.

To view the letter, click here.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

View Current Issue

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi